131 related articles for article (PubMed ID: 21651812)
21. Synergistic induction of apoptosis by the Bcl-2 inhibitor ABT-737 and imatinib mesylate in gastrointestinal stromal tumor cells.
Reynoso D; Nolden LK; Yang D; Dumont SN; Conley AP; Dumont AG; Zhou K; Duensing A; Trent JC
Mol Oncol; 2011 Feb; 5(1):93-104. PubMed ID: 21115411
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of vinorelbine-induced cytotoxicity and apoptosis by clomipramine and lithium chloride in human neuroblastoma cancer cell line SH-SY5Y.
Bilir A; Erguven M; Yazihan N; Aktas E; Oktem G; Sabanci A
J Neurooncol; 2010 Dec; 100(3):385-95. PubMed ID: 20467784
[TBL] [Abstract][Full Text] [Related]
23. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
[TBL] [Abstract][Full Text] [Related]
24. Anticancer activity of Noscapine, an opioid alkaloid in combination with Cisplatin in human non-small cell lung cancer.
Chougule M; Patel AR; Sachdeva P; Jackson T; Singh M
Lung Cancer; 2011 Mar; 71(3):271-82. PubMed ID: 20674069
[TBL] [Abstract][Full Text] [Related]
25. MDA-7 regulates cell growth and radiosensitivity in vitro of primary (non-established) human glioma cells.
Yacoub A; Mitchell C; Hong Y; Gopalkrishnan RV; Su ZZ; Gupta P; Sauane M; Lebedeva IV; Curiel DT; Mahasreshti PJ; Rosenfeld MR; Broaddus WC; James CD; Grant S; Fisher PB; Dent P
Cancer Biol Ther; 2004 Aug; 3(8):739-51. PubMed ID: 15197348
[TBL] [Abstract][Full Text] [Related]
26. A polymethoxyflavone from Laggera pterodonta induces apoptosis in imatinib-resistant K562R cells via activation of the intrinsic apoptosis pathway.
Cao C; Liu B; Zeng C; Lu Y; Chen S; Yang L; Li B; Li Y; Li Y
Cancer Cell Int; 2014; 14(1):137. PubMed ID: 25530716
[TBL] [Abstract][Full Text] [Related]
27. Resistance of human glioblastoma multiforme cells to growth factor inhibitors is overcome by blockade of inhibitor of apoptosis proteins.
Ziegler DS; Wright RD; Kesari S; Lemieux ME; Tran MA; Jain M; Zawel L; Kung AL
J Clin Invest; 2008 Sep; 118(9):3109-22. PubMed ID: 18677408
[TBL] [Abstract][Full Text] [Related]
28. Enhanced anticancer activity of combined treatment of imatinib and dipyridamole in solid Ehrlich carcinoma-bearing mice.
El-Sisi AE; Sokar SS; Ibrahim HA; Abu-Risha SE
Naunyn Schmiedebergs Arch Pharmacol; 2020 Jun; 393(6):1113-1129. PubMed ID: 31950222
[TBL] [Abstract][Full Text] [Related]
29. The novel pyrrolo-1,5-benzoxazepine, PBOX-15, synergistically enhances the apoptotic efficacy of imatinib in gastrointestinal stromal tumours; suggested mechanism of action of PBOX-15.
Kinsella P; Greene LM; Bright SA; Pollock JK; Butini S; Campiani G; Bauer S; Williams DC; Zisterer DM
Invest New Drugs; 2016 Apr; 34(2):159-67. PubMed ID: 26885657
[TBL] [Abstract][Full Text] [Related]
30. Imatinib mesylate (Gleevec) inhibits ovarian cancer cell growth through a mechanism dependent on platelet-derived growth factor receptor alpha and Akt inactivation.
Matei D; Chang DD; Jeng MH
Clin Cancer Res; 2004 Jan; 10(2):681-90. PubMed ID: 14760091
[TBL] [Abstract][Full Text] [Related]
31. Combined EGFR and autophagy modulation impairs cell migration and enhances radiosensitivity in human glioblastoma cells.
Palumbo S; Tini P; Toscano M; Allavena G; Angeletti F; Manai F; Miracco C; Comincini S; Pirtoli L
J Cell Physiol; 2014 Nov; 229(11):1863-73. PubMed ID: 24691646
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical analysis of platelet-derived growth factor receptor-alpha, -beta, c-kit, c-abl, and arg proteins in glioblastoma: possible implications for patient selection for imatinib mesylate therapy.
Haberler C; Gelpi E; Marosi C; Rössler K; Birner P; Budka H; Hainfellner JA
J Neurooncol; 2006 Jan; 76(2):105-9. PubMed ID: 16205964
[TBL] [Abstract][Full Text] [Related]
33. Methylglyoxal (MGO) inhibits proliferation and induces cell death of human glioblastoma multiforme T98G and U87MG cells.
Paul-Samojedny M; Łasut B; Pudełko A; Fila-Daniłow A; Kowalczyk M; Suchanek-Raif R; Zieliński M; Borkowska P; Kowalski J
Biomed Pharmacother; 2016 May; 80():236-243. PubMed ID: 27133062
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-153-3p enhances the sensitivity of chronic myeloid leukemia cells to imatinib by inhibiting B-cell lymphoma-2-mediated autophagy.
Li YL; Tang JM; Chen XY; Luo B; Liang GH; Qu Q; Lu ZY
Hum Cell; 2020 Jul; 33(3):610-618. PubMed ID: 32342278
[TBL] [Abstract][Full Text] [Related]
35. Antitumor activity of noscapine in human non-small cell lung cancer xenograft model.
Jackson T; Chougule MB; Ichite N; Patlolla RR; Singh M
Cancer Chemother Pharmacol; 2008 Dec; 63(1):117-26. PubMed ID: 18338172
[TBL] [Abstract][Full Text] [Related]
36. Feasibility of administering oblimersen (G3139; Genasense) with imatinib mesylate in patients with imatinib resistant chronic myeloid leukemia--Cancer and leukemia group B study 10107.
Wetzler M; Donohue KA; Odenike OM; Feldman EJ; Hurd DD; Stone RM; Westerfelt P; Bloomfield CD; Larson RA
Leuk Lymphoma; 2008 Jul; 49(7):1274-8. PubMed ID: 18452072
[TBL] [Abstract][Full Text] [Related]
37. Combination of Salinomycin and AZD3463 Reveals Synergistic Effect on Reducing the Viability of T98G Glioblastoma Cells.
Asik A; Ay NPO; Bagca BG; Caglar HO; Gunduz C; Avci CB
Anticancer Agents Med Chem; 2020; 20(18):2267-2273. PubMed ID: 32698744
[TBL] [Abstract][Full Text] [Related]
38. Synergy between proteasome inhibitors and imatinib mesylate in chronic myeloid leukemia.
Hu Z; Pan XF; Wu FQ; Ma LY; Liu DP; Liu Y; Feng TT; Meng FY; Liu XL; Jiang QL; Chen XQ; Liu JL; Liu P; Chen Z; Chen SJ; Zhou GB
PLoS One; 2009 Jul; 4(7):e6257. PubMed ID: 19606213
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms involved in the cell cycle and apoptosis of HT-29 cells pre-treated with MK-886 prior to photodynamic therapy with hypericin.
Kleban J; Mikes J; Horváth V; Sacková V; Hofmanová J; Kozubík A; Fedorocko P
J Photochem Photobiol B; 2008 Nov; 93(2):108-18. PubMed ID: 18771933
[TBL] [Abstract][Full Text] [Related]
40. The novel tyrosine kinase inhibitor EXEL-0862 induces apoptosis in human FIP1L1-PDGFR-alpha-expressing cells through caspase-3-mediated cleavage of Mcl-1.
Pan J; Quintás-Cardama A; Manshouri T; Giles FJ; Lamb P; Tefferi A; Cortes J; Kantarjian H; Verstovsek S
Leukemia; 2007 Jul; 21(7):1395-404. PubMed ID: 17495975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
